Duke Capital Partners — 2024 Investments
1 investments dated 2024 · listed companies and verified rows first · show all
VQ Biomedical is developing a minimally-invasive intravascular catheter that delivers supplemental oxygen directly into the bloodstream of hospitalized patients with respiratory failure, providing gas exchange independent of the lungs.
BiotechHealthtechMedical DevicesApex, US
Galen Robertson(Co-founder & CEO)inTobias Straube(Co-founder & Chief Medical Officer)Stewart Farling(Co-founder & Lead Engineer)inMarc Deshusses(Co-founder & Principal Scientist)inBruce Klitzman(Co-founder & Scientific Advisor)in
BoardDaniel E. Estay(Director)in
Co-investorsWolfpack Investor NetworkDCP Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.


